TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults.

Christina A Rostad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.